Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low Dose vs Weight-based Acyclovir for HSV Prophylaxis in Neutropenia
NCT00855309Phase 3Completed
- Sponsor
- Wake Forest University Health Sciences
- Start
- Nov 2008
- Primary completion
- Nov 2013
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 3 trial of aciclovir in herpes simplex (HSV), sponsored by Wake Forest University Health Sciences. Started Nov 2008; status: completed.
02
Drugs
aciclovir
03
Conditions
herpes simplex (HSV)
Beyond the preview
Go deeper on NCT00855309.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00855309.